NuTech NuCel: A Prospective, Efficacy Study of NuCel in Patients Undergoing Fusion for One, Two or Three Level Degenerative Disease of the Lumbar Spine.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Apr 2018
At a glance
- Drugs Amniotic cell therapy-NuCel (Primary)
- Indications Intervertebral disc degeneration
- Focus Therapeutic Use
- Sponsors Nutech Medical
- 02 Apr 2018 Planned End Date changed from 1 Dec 2018 to 1 Aug 2020.
- 02 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 14 Sep 2017 Planned End Date changed from 1 Jan 2018 to 1 Dec 2018.